# Haemonetics Corporation (HAE): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Haemonetics Corporation (HAE) is 84/100, ranked against 24,000+ stocks in 35 markets (Quality 66, Value 35, Momentum 80, each scored against its sector).

- StockRank: 84/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 66, Value 35, Momentum 80: each a 0-100 percentile within Healthcare.
- Position: #4,392 overall, #499 in Healthcare.
- Listing: United States, NYQ; Healthcare / Medical Devices.
- Last close: 118.51 USD on 23 Oct 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.
- Buybacks, last 180 days: the company bought back USD 250.0M on 1 day.

Source: https://moatmap.ai/stock/HAE
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker